NCT00979433

Brief Summary

The objective of this study is to evaluate whether CPAP delivered by bubble CPAP resulted in a greater proportion of infants being successfully extubated when compared with management with ventilator derived CPAP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

September 17, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 18, 2009

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

February 26, 2013

Status Verified

February 1, 2013

Enrollment Period

2.2 years

First QC Date

September 17, 2009

Last Update Submit

February 23, 2013

Conditions

Keywords

Extubation failureContinuous positive airway pressureBubble CPAP

Outcome Measures

Primary Outcomes (1)

  • Extubation failure - defined as need for reintubation and mechanical ventilation for any reason within 72 hours of initial extubation

    Till 72 hours after extubation

Secondary Outcomes (1)

  • Time to extubation failure in hours.

    till extubation failure within first 72 hours after extubation

Study Arms (2)

Bubble CPAP

EXPERIMENTAL

All neonates randomised to bubble CPAP will be put on Bubble CPAP following initial extubation in first week of life.

Device: Bubble CPAP

Conventional CPAP

OTHER

All neonates randomly allocated to conventional/ventilator derived CPAP.

Device: Conventional CPAP

Interventions

Bubble CPAP will be delivered using Fischer \& Paykel CPAP system with a starting flow of 6 liters/minute. CPAP will be initially started at a pressure of 5 - 6 cm H2O and fraction of inspired oxygen (FiO2) of 0.4 - 0.5. which will be adjusted to maintain oxygen saturation (SpO2) between 87 and 93%.

Also known as: Fisher & Paykel Bubble CPAP System
Bubble CPAP

Conventional CPAP will be delivered using Argyle CPAP (Sherwood Medical Company, Mexico) short nasal prongs with warm, humidified gas used (34-37°C) through a thermo-statically controlled humidifier, flow @ 4-8 L/min from either SLE 2000 pressure-controlled continuous flow ventilator (Specialized Laboratory Equipment, UK) or Baby log 8000 volume guarantee ventilator.

Conventional CPAP

Eligibility Criteria

AgeUp to 7 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestation less than 32 weeks
  • Birth weight less than 1500 g
  • Age less than seven days
  • First extubation attempt.

You may not qualify if:

  • A neonate having any of the following will be excluded from the study-
  • Severe birth asphyxia defined as need for chest compression for more than 30 seconds
  • Suspected congenital neuromuscular disorder
  • Major congenital malformation
  • Grade 3/4 interventricular haemorrhage
  • Hydrops.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All India Institute of Medical Sciences

New Delhi, National Capital Territory of Delhi, India

Location

Study Officials

  • Vinod K Paul, MD PhD

    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi

    STUDY CHAIR
  • Sucheta Yadav, MBBS

    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi

    PRINCIPAL INVESTIGATOR
  • Mari J Sankar, MD, DM

    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi

    STUDY CHAIR
  • Ramesh Agarwal, MD, DM

    Department of Pediatrics, All India Institute of Medical Sciences, New Delhi

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 17, 2009

First Posted

September 18, 2009

Study Start

September 1, 2007

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

February 26, 2013

Record last verified: 2013-02

Locations